英文名稱 |
中文名稱 |
CAS號 |
操作 |
Hibifolin |
棉皮素-8-O-Β-D-葡萄糖醛酸苷 |
55366-56-8 |
詳細(xì)
|
Benzonatate |
苯佐那酯 |
104-31-4 |
詳細(xì)
|
Galunisertib |
LY 2157299 |
700874-72-2 |
詳細(xì)
|
Azvudine |
4-氨基-1-(4-C-疊氮基-2-脫氧-2-氟-BETA-D-呋喃阿拉伯糖基)-2(1H)-嘧啶酮 |
1011529-10-4 |
詳細(xì)
|
Valiltramiprosate |
化合物ALZ-801 |
1034190-08-3 |
詳細(xì)
|
HIV-1 inhibitor-58 |
奈韋拉平D4 |
1051418-95-1 |
詳細(xì)
|
DODMA |
1,2-二油醇-3-二甲基氨基-丙烷 |
104162-47-2 |
詳細(xì)
|
E1231 |
E1231 |
1031195-19-3 |
詳細(xì)
|
Calenduloside E |
SNX-0723 |
1073969-18-2 |
詳細(xì)
|
Betaine |
甜菜堿 |
107-43-7 |
詳細(xì)
|
IRAK4-IN-6 |
化合物 T11674 |
2454244-02-9 |
詳細(xì)
|
5-Fluoro-2'-deoxycytidine |
5-氟脫氧胞苷 |
10356-76-0 |
詳細(xì)
|
SB-505124 |
SB-505124 |
694433-59-5 |
詳細(xì)
|
L-Leucine-d |
N-[4-[4-(4-嗎啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯 |
1062161-90-3 |
詳細(xì)
|
MDR-1339 |
DWK-1339 |
1018946-38-7 |
詳細(xì)
|
LDN-212854 |
(LDN212854) |
1432597-26-6 |
詳細(xì)
|
Ganoderic acid C6 |
靈芝酸C6 |
105742-76-5 |
詳細(xì)
|
Oct3/4-inducer-1 |
2-(4-(4-氟芐基)氧基)苯基)乙腈 |
1016535-83-3 |
詳細(xì)
|
CL097 |
化合物CL097 |
1026249-18-2 |
詳細(xì)
|
5,7-Dimethoxyluteolin |
5,7-二甲氧基木犀草素 |
90363-40-9 |
詳細(xì)
|
PF-6274484 |
PF-6274484 |
1035638-91-5 |
詳細(xì)
|
Vactosertib Hydrochloride |
EW-7197 |
1352610-25-3 |
詳細(xì)
|
PF-06952229 |
PF-06952229 |
1801333-55-0 |
詳細(xì)
|
GRL-0496 |
化合物GRL-0496 |
1087243-14-8 |
詳細(xì)
|
Cefacetrile |
頭孢乙氰 |
10206-21-0 |
詳細(xì)
|
AKB-6899 |
Glycine, N-[[5-(3-fluorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]- |
1007377-55-0 |
詳細(xì)
|
Diclofensine hydrochloride |
4-(3,4-二氯苯)-7-甲氧基-2-甲基-1,2,3,4-四氫異喹啉鹽酸鹽 |
34041-84-4 |
詳細(xì)
|
HZ-1157 |
5-叔丁氧基-2,4-二氨基喹唑啉 |
1009734-33-1 |
詳細(xì)
|
AEM1 |
AEM1 |
1030123-90-0 |
詳細(xì)
|
Nelonicline |
Nelonicline |
1026134-63-3 |
詳細(xì)
|
GBR 12935 dihydrochloride |
GBR-12935 dihydrochloride |
67469-81-2 |
詳細(xì)
|
Levetiracetam-d |
(2S)-4,4,4-trideuterio-2-(2-oxopyrrolidin-1-yl)butanamide |
1217851-16-5 |
詳細(xì)
|
FKGK18 |
FKGK18 |
1071001-09-6 |
詳細(xì)
|
ML359 |
ML359 |
1069858-99-6 |
詳細(xì)
|
PPNDS tetrasodium |
PYRIDOXAL-5'-PHOSPHATE-6-(2'-NAPHTHYLAZO-6'-NITRO-4',8'-DISULFONATE) TETRASODIUM SALT |
1021868-77-8 |
詳細(xì)
|
8-Azaadenosine |
8-AZAADENOSINE |
10299-44-2 |
詳細(xì)
|
Camrelizumab |
Camrelizumab |
1798286-48-2 |
詳細(xì)
|
Artemisitene |
青蒿烯 |
101020-89-7 |
詳細(xì)
|
Dup-721 |
4-acetylphenyloxooxazolidinylmethylacetamide |
104421-21-8 |
詳細(xì)
|
Fumagillol |
煙曲霉醇 |
108102-51-8 |
詳細(xì)
|
Xevinapant hydrochloride |
AT-406 |
1071992-57-8 |
詳細(xì)
|
IRAK inhibitor 2 |
4-[6-[[(呋喃-2-基)甲基]氨基]咪唑并[1,2-B]噠嗪-3-基]苯酚 |
928333-30-6 |
詳細(xì)
|
IRAK inhibitor 3 |
4-[[[3-(3,4-二甲氧基苯基)咪唑并[1,2-B]噠嗪-6-基]氨基]甲基]苯磺酰胺 |
1012343-93-9 |
詳細(xì)
|
CVT-11127 |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氫吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
詳細(xì)
|
Lin28-let-7 antagonist 1 |
N-METHYL-N-[3-(3-METHYL[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-6-YL)PHENYL]ACETAMIDE |
108825-65-6 |
詳細(xì)
|
Etamicastat hydrochloride |
Etamicastat HCl salt |
677773-32-9 |
詳細(xì)
|
MJ33 lithium salt |
GDLMLQJISATCEL-UHFFFAOYSA-M |
1007476-63-2 |
詳細(xì)
|
CIM0216 |
N-(5-methyl-1,2-oxazol-3-yl)-2-phenyl-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide |
1031496-06-6 |
詳細(xì)
|
PF-06426779 |
PF-06426779 |
1817628-40-2 |
詳細(xì)
|
LY-364947 |
LY 364947 |
396129-53-6 |
詳細(xì)
|
Ganoderol B |
GANODEROL B |
104700-96-1 |
詳細(xì)
|
1-Deazaadenosine |
1-去氮雜腺苷 |
14432-09-8 |
詳細(xì)
|
LMPTP inhibitor 1 hydrochloride |
化合物 T23193 |
1052089-16-3 |
詳細(xì)
|
HCV-IN-30 |
達(dá)卡他韋中間體II |
1007882-23-6 |
詳細(xì)
|
Vactosertib |
EW-7197 |
1352608-82-2 |
詳細(xì)
|
BC-1382 |
化合物BC-1382 |
1013753-99-5 |
詳細(xì)
|
7BIO |
5-氨基-2-(2,6-二異丙基苯基)異吲哚啉-1,3-二酮 |
100823-03-8 |
詳細(xì)
|
Fusaric acid |
萎蔫酸 |
536-69-6 |
詳細(xì)
|
Sonepiprazole |
SONEPIPRAZOLE |
170858-33-0 |
詳細(xì)
|
BIBF0775 |
BIBF0775 |
334951-90-5 |
詳細(xì)
|
Gardiquimod |
4-氨基-2-[(乙基氨基)甲基]-ALPHA,ALPHA-二甲基-1H-咪唑并[4,5-C]喹啉-1-乙醇 |
1020412-43-4 |
詳細(xì)
|
AHN 1-055 hydrochloride |
-Bis-(4-fluorophenyl) methoxytropane hydrochloride |
202646-03-5 |
詳細(xì)
|
RVX-297 |
RVX297 |
1044871-04-6 |
詳細(xì)
|
RO5203648 |
RO-5203648 |
1043491-54-8 |
詳細(xì)
|
CP-24879 hydrochloride |
CP-24879 HYDROCHLORIDE |
10141-51-2 |
詳細(xì)
|
Terevalefim |
ANG-3777 |
1070881-42-3 |
詳細(xì)
|
SPD304 dihydrochloride |
TNF-α inhibitor |
1049741-03-8 |
詳細(xì)
|
AR453588 |
AR453588 |
1065609-00-8 |
詳細(xì)
|
GSK-1482160 |
(S)-(N)-2-氯-3-(三氟甲基)芐基)-1-甲基-5-氧吡咯烷-2-甲酰胺 |
1001389-72-5 |
詳細(xì)
|
ALK2-IN-4 |
無中文名稱 |
2248154-85-8 |
詳細(xì)
|
Glemanserin |
ALPHA-PHENYL-1-(2-PHENYLETHYL)-4-PIPERIDINEMETHANOL |
107703-78-6 |
詳細(xì)
|
AZD 4017 |
AZD 4017 |
1024033-43-9 |
詳細(xì)
|
PF-06650833 |
PF-06650833 |
1817626-54-2 |
詳細(xì)
|
(E/Z)-Teriflunomide |
2-氰基-3-羥基-N-(4-三氟甲基苯基)巴豆酰胺 |
108605-62-5 |
詳細(xì)
|
GK187 |
GK187 |
1071001-50-7 |
詳細(xì)
|
ABC1183 |
ABC1183; ABC-1183; ABC 1183 |
1042735-18-1 |
詳細(xì)
|
LDN193189 Tetrahydrochloride |
LDN193189 Tetrahydrochloride |
2310134-98-4 |
詳細(xì)
|
BMP signaling agonist sb4 |
SB 4 |
100874-08-6 |
詳細(xì)
|
A 77-01 |
A 77-01 |
607737-87-1 |
詳細(xì)
|
CD1530 |
CD1530 |
107430-66-0 |
詳細(xì)
|
Ganoderenic acid B |
靈芝烯酸B |
100665-41-6 |
詳細(xì)
|
IRAK inhibitor 4 |
1-(4-羥基環(huán)己基)-2-[[5-(2-三氟甲氧基苯基)-1H-吲唑-3-基]氨基]-1H-苯并咪唑-5-羧酸 (3-甲基丁基)酰胺 |
1012104-68-5 |
詳細(xì)
|
AZ1495 |
AZ1495 |
2196204-23-4 |
詳細(xì)
|
SD-208 |
SD-208 |
627536-09-8 |
詳細(xì)
|
Alkynyl Stearic Acid |
17-十八炔酸 |
34450-18-5 |
詳細(xì)
|
IRAK inhibitor 1 |
環(huán)巴胺抑制劑 1 |
1042224-63-4 |
詳細(xì)
|
ML347 |
(ML347) |
1062368-49-3 |
詳細(xì)
|
ABT-702 dihydrochloride |
ABT 702 DIHYDROCHLORIDE(二鹽酸鹽) |
1188890-28-9 |
詳細(xì)
|
Adenosine deaminase |
腺苷脫氨酶 |
9026-93-1 |
詳細(xì)
|
Gossypol (acetic acid) |
醋酸棉酚 |
12542-36-8 |
詳細(xì)
|
DOTMA |
1,2-雙十八烯氧基-3-甲基銨丙烷氯鹽 |
104872-42-6 |
詳細(xì)
|
Tepoxalin |
替泊沙林 |
103475-41-8 |
詳細(xì)
|
N-Hexanoyl-DL-homoserine lactone |
N-己酰基- DL -高絲氨酸內(nèi)酯 |
106983-28-2 |
詳細(xì)
|
L-364,373 |
化合物 T22894 |
103342-82-1 |
詳細(xì)
|
RO-3 |
5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
1026582-88-6 |
詳細(xì)
|
LDN-214117 |
化合物L(fēng)DN-214117 |
1627503-67-6 |
詳細(xì)
|
Dagrocorat |
DAGROCORAT |
1044535-52-5 |
詳細(xì)
|
Isosaponarin |
異肥皂草苷 |
19416-87-6 |
詳細(xì)
|
Levophacetoperane hydrochloride |
左法哌酯鹽酸鹽 |
23257-56-9 |
詳細(xì)
|
IRAK-1-4 Inhibitor I |
IRAK-1-4 抑制劑 I |
509093-47-4 |
詳細(xì)
|